Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vaccinex Inc (VCNX)

Vaccinex Inc (VCNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 70,226
  • Shares Outstanding, K 30,801
  • Annual Sales, $ 630 K
  • Annual Income, $ -28,850 K
  • 60-Month Beta 1.73
  • Price/Sales 110.88
  • Price/Cash Flow N/A
  • Price/Book 4.03
Trade VCNX with:

Options Overview

Details
  • Implied Volatility 146.33%
  • Historical Volatility 38.92%
  • IV Percentile 44%
  • IV Rank 18.24%
  • IV High 387.31% on 09/21/20
  • IV Low 92.58% on 08/20/21
  • Put/Call Vol Ratio 0.12
  • Today's Volume 29
  • Volume Avg (30-Day) 93
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 3,169
  • Open Int (30-Day) 2,828

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +227,145.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.15 +6.05%
on 08/20/21
2.53 -9.88%
on 08/27/21
+0.06 (+2.70%)
since 08/17/21
3-Month
2.12 +7.55%
on 08/17/21
2.94 -22.45%
on 06/28/21
-0.44 (-16.18%)
since 06/17/21
52-Week
1.63 +39.88%
on 09/29/20
9.56 -76.15%
on 02/19/21
-3.65 (-61.55%)
since 09/17/20

Most Recent Stories

More News
Vaccinex to Present at the Oppenheimer & Co. Inc. Fall Healthcare Life Sciences and MedTech Summit

Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology Company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D, a potent biological...

VCNX : 2.28 (+1.33%)
Vaccinex CEO, Dr. Maurice Zauderer, Presented New and Promising Phase 2 SIGNAL Trial Data in a Plenary Session at the European Huntington's Disease Network Meeting

Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology Company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D, a potent biological...

VCNX : 2.28 (+1.33%)
Extensive Demand for T-Cell Adoptive Immunotherapy Rising with Growing Prevalence of Cancer

PALM BEACH,  Fla., /PRNewswire/ -- In the breast cancer therapy market, the rise in the prevalence of cancer, has propelled the T-cell therapy market over the last few years and it is projected to continue...

ONCY : 2.01 (-3.83%)
ONC.TO : 2.68 (+3.47%)
VCNX : 2.28 (+1.33%)
PDSB : 14.93 (-1.39%)
CTXR : 2.08 (unch)
CLVS : 4.84 (+4.99%)
Thinking about buying stock in Sundial Growers, Vaccinex, JMP Group, Seelos Therapeutics, or Northern Dynasty Minerals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, VCNX, JMP, SEEL, and NAK.

NAK : 0.4900 (+1.66%)
SEEL : 2.0000 (+1.52%)
SNDL : 0.7254 (+0.85%)
VCNX : 2.28 (+1.33%)
JMP : 7.48 (unch)
Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech

Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech

VIVO : 20.00 (+2.67%)
BLCM : 3.15 (+7.14%)
VCNX : 2.28 (+1.33%)
QFIN : 20.77 (-1.14%)
LMNL : 2.70 (-2.17%)
Bet on Rising P/E With These 5 Top-Ranked Stocks

Want to try some out-of-the-box approach? Tap five stocks with increasing P/E ratios.

BJ : 58.74 (-0.27%)
VIVO : 20.00 (+2.67%)
BLCM : 3.15 (+7.14%)
VCNX : 2.28 (+1.33%)
QFIN : 20.77 (-1.14%)
LMNL : 2.70 (-2.17%)
Vaccinex Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Additional data from SIGNAL Huntington's disease (HD) trial support continued development in HD and in Alzheimer's disease (AD)

VCNX : 2.28 (+1.33%)
CORRECTION -- Vaccinex to Present Additional SIGNAL Data at Huntington Study Group 2020 Medical Conference

SIGNAL Phase 2 trial data continue to support cognitive benefit and reduced brain atrophy with pepinemab treatment in Huntington's disease

VCNX : 2.28 (+1.33%)
Vaccinex to Present Additional SIGNAL Data at Huntington Study Group 2020 Medical Conference

SIGNAL Phase 2 trial data continue to support cognitive benefit and reduced brain atrophy with pepinemab treatment in Huntington's disease

VCNX : 2.28 (+1.33%)
Vaccinex, Inc. to Present at the Virtual Investor KOL Roundtable

Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, announced today...

VCNX : 2.28 (+1.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Vaccinex, Inc. is a clinical-stage immunotherapy company. It engages in the discovery and development of biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases and autoimmune disorders. The company's product pipeline consists of...

See More

Key Turning Points

3rd Resistance Point 2.50
2nd Resistance Point 2.42
1st Resistance Point 2.35
Last Price 2.28
1st Support Level 2.20
2nd Support Level 2.11
3rd Support Level 2.04

See More

52-Week High 9.56
Fibonacci 61.8% 6.53
Fibonacci 50% 5.60
Fibonacci 38.2% 4.66
Last Price 2.28
52-Week Low 1.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar